Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001493152-24-036076

CEO & President acquired 312,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Equels Thomas K CEO & President 2024-09-11 Grant or award +312,500 $0.32 $100,000 1,468,042 D
Loading xslF345X05/ownership.xml…